Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Team Grant: Canadian Microbiome Initiative 2: Research Teams - LOI

McMaster University

$24,900.00

The role of gut microbiota in chronic abdominal pain.

FY 2018-19

Summary
Chronic abdominal pain, the pain we feel when our stomach and bowels are inflamed, diseased, or injured, is by far the most common type of pain. Although abdominal pain is particularly prevalent in women, for both men and women the abdominal pain is one of the most common reasons for consulting a doctor. Abdominal pain is not always linked to gut injury, it can be present even in patients without any intestinal ulcers or overt inflammation, such as patients with Irritable Bowel Syndrome (IBS). Abdominal pain is difficult to treat as its cause is often unknown, and it sometimes can lead to dependency on opioid medications. There is accumulating data that gut bacteria can alter gut function and pain perception, through production of metabolites which act on the sensory nerves in the gut. We have shown that some bacteria from selected patients with IBS can produce these metabolites and lead to increased pain sensation in mice. In this project we propose to study gut bacteria profiles in large cohorts of patients with IBS and other chronic gut disorders (without signs of overt intestinal inflammation or injury) and compare those with severe chronic abdominal pain to those without any pain. We hope to identify specific bacteria associated with abdominal pain, which would be then investigated using combination of different molecular and physiological techniques in animal models. The ultimate goal is to find the underlying mechanisms and bacterial biomarkers (molecular signatures of pain) which would identify the patients in whom bacteria-based treatments would be indicated.
Program
Team Grant: Canadian Microbiome Initiative 2: Research Teams - LOI
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
399182
Name
Bercik Premysl
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Team Grant : Canadian Microbiome Initiative 2: Research Teams
Projecttitle
The role of gut microbiota in chronic abdominal pain.
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$24,900
Cihrequipment2
$0
Programname2
Team Grant: Canadian Microbiome Initiative 2: Research Teams - LOI
Keyworddelim
Animal Models; Celiac Disease; Inflammatory Bowel Disorders; Irritable Bowel Syndrome; Metabolomics; Microbiome; Pain; Translational Research; Visceral Hypersensitivity
Abstract
Chronic abdominal pain, the pain we feel when our stomach and bowels are inflamed, diseased, or injured, is by far the most common type of pain. Although abdominal pain is particularly prevalent in women, for both men and women the abdominal pain is one of the most common reasons for consulting a doctor. Abdominal pain is not always linked to gut injury, it can be present even in patients without any intestinal ulcers or overt inflammation, such as patients with Irritable Bowel Syndrome (IBS). Abdominal pain is difficult to treat as its cause is often unknown, and it sometimes can lead to dependency on opioid medications. There is accumulating data that gut bacteria can alter gut function and pain perception, through production of metabolites which act on the sensory nerves in the gut. We have shown that some bacteria from selected patients with IBS can produce these metabolites and lead to increased pain sensation in mice. In this project we propose to study gut bacteria profiles in large cohorts of patients with IBS and other chronic gut disorders (without signs of overt intestinal inflammation or injury) and compare those with severe chronic abdominal pain to those without any pain. We hope to identify specific bacteria associated with abdominal pain, which would be then investigated using combination of different molecular and physiological techniques in animal models. The ultimate goal is to find the underlying mechanisms and bacterial biomarkers (molecular signatures of pain) which would identify the patients in whom bacteria-based treatments would be indicated.
Competitiondate
201811
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bercik, Premysl; Reed, David E; Vanner, Stephen J
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Infection & Immunity~ $24,900~ $0~